Information Letter on Reminyl®: Serious skin reactions; Stevens-Johnson Syndrome and acute generalised exanthematous pustulosis
2015.09.22
Active substance: Galantaminhydrobromid
The company Janssen-Cilag is circulating information on a new warning for Reminyl®.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN